Le Lézard
Classified in: Health, Science and technology
Subject: LAW/LEGAL ISSUES

Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore


CHARLESTON, S.C., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the "Company" or "Aeterna Zentaris") (NASDAQ:AEZS) (TSX:AEZS), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced today that it is in receipt of a statement of defence and counterclaim filed by former officers David Dodd ("Dodd") and Philip Theodore ("Theodore") in Ontario in connection with the Company's previously disclosed litigation against Dodd and Theodore. The counterclaim against the Company and its Chair, Carolyn Egbert, alleges, among other things, that defamatory statements in respect of Dodd and Theodore were made in a Company press release, and claims damages of $6 million.

The Company and its Chair consider the counterclaim against them to be entirely without merit, and intend to vigorously defend against the counterclaim.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on developing and commercializing Macrilentm (macimorelin), an orally available ghrelin agonist, to be used in the diagnosis of patients with adult growth hormone deficiency (AGHD). On December 20, 2017 the Company announced that the U.S. Food and Drug Administration (FDA) granted marketing approval for Macrilentm (macimorelin). On November 27, 2017 Aeterna Zentaris announced that the Marketing Authorization Application (MAA) for the use of Macrilentm (macimorelin) for the evaluation of AGHD was accepted by the European Medicines Agency (EMA) for regulatory review. For more information, visit www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe-harbor provisions of the U.S. Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, which reflect our current expectations regarding future events. Forward-looking statements may include, but are not limited to statements preceded by, followed by, or that include the words "expects," "believes," "intends," "would," "could," "may," "anticipates," and similar terms that relate to future events, performance, or our results. Forward-looking statements involve known risks and uncertainties, many of which are discussed under the caption "Key Information - Risk Factors" in our most recent Annual Report on Form 20-F filed with the relevant Canadian securities regulatory authorities in lieu of an annual information form and with the U.S. Securities and Exchange Commission ("SEC") and under the caption "Risk Factors and Uncertainties" in our management's discussion and analysis for the third quarter of 2017. Such statements include, but are not limited to, statements about the merit or outcome of the litigation involving Dodd and Theodore, and the Company's and its Chair's intention and ability to defend such legal actions. Known and unknown risks and uncertainties could cause our actual results to differ materially from those in forward-looking statements. Such risks and uncertainties include, effect of the litigation involving Dodd and Theodore and other litigation, on our cash flow, results of operations and financial position. Investors should consult the Company's quarterly and annual filings with the applicable Canadian securities regulators and the SEC for additional information on risks and uncertainties. Given these uncertainties and risk factors, readers are cautioned not to place undue reliance on these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, unless required to do so by a governmental authority or applicable law.

Contacts:

Aeterna Zentaris Inc.
Michael V. Ward
Chief Executive Officer
[email protected]
843-900-3201

Reilly Connect
Susan Reilly
President
[email protected]
312-600-6783


These press releases may also interest you

at 18:18
NASA is awarding approximately $3.7 million to 17 museums, science centers, and other informal education institutions as part of an initiative to ignite STEM excitement. The money will go toward projects that inspire students and their learning...

at 18:15
Epiq, a global technology-enabled leader to the legal industry and corporations, announced today Epiq Facilitatortm the premier, reliable, secure application for retrieving information, managing legal analysis, and administering voluntary...

at 18:15
The "Industrial Ovens - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Industrial Ovens estimated at US$10.8 Billion in the year 2023, is projected to reach a revised size of US$14.8...

at 18:15
The acquisition solidifies ValeU Group as one of the premier firms in the nation offering Fortune 500 companies and smaller...

at 18:05
CrowdStrike announced the winners of the annual CrowdStrike Asia Pacific and Japan (APJ) Partner Awards at the CrowdStrike Partner Symposium in Bangkok. The awards recognize the exceptional work the partner ecosystem accomplished, supporting...

at 18:00
Descartes Systems Group , the global leader in uniting logistics-intensive businesses in commerce, announced that it has acquired OCR Services, Inc. ("OCR"), a leading provider of global trade compliance solutions and content. OCR specializes in...



News published on and distributed by: